Bracco touts contrast study results

AuntMinnie.com staff writers
Aug 4, 2008

Italian contrast firm Bracco said that results from the Patients with Renal Impairment and Diabetes undergoing CT (PREDICT) trial show no statistically significant difference between its Isovue-370 low-osmolar CT contrast agent and the Visipaque 320 isomolar agent (GE Healthcare, Chalfont St. Giles, U.K.) in the rate of contrast-induced nephropathy in high-risk patients undergoing CT studies.

The results were recently published in the American Journal of Roentgenology, according to Bracco of Milan.

Related Reading

Bracco completes E-Z-EM acquisition, April 2, 2008

Bracco to acquire E-Z-EM, October 30, 2007

Bracco, ImaRx sign licensing pact, July 4, 2007

Copyright © 2008 AuntMinnie.com

Latest in CT
Artificial Intelligence Ai Social
AI stroke software differences don't affect thrombectomy eligibility
May 3, 2024
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
May 1, 2024
2024 04 30 Radiology Choi Figure2 Thumbnail
Interstitial lung abnormalities linked to respiratory disease risk
April 30, 2024
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
Understanding CT flow artifacts is key to better disease diagnosis
April 26, 2024
Related Stories
2008 08 04 14 57 09 176 Steigner thumb 08 08
CT
Prospective gating minimizes dose in 320-slice CTA
2008 07 29 15 07 35 970 Freedman thumb 08 08
CT
Novel CAD concept reduces lung nodule false positives
2008 07 29 11 21 52 52 Nappi thumb 08 08
CT
Image tools cut false positives in unprepped VC
You think ahead. We innovate ahead.
Sponsor Content
You think ahead. We innovate ahead.
More in CT
AI stroke software differences don't affect thrombectomy eligibility
By Liz Carey
The research findings suggest, however, that scanner model and local CT perfusion protocols can influence performance and cause discrepancies.
May 3, 2024
Artificial Intelligence Ai Social
Volumetric CT helps predict lung-lobectomy complications
By Kate Madden Yee
Volumetric CT imaging analysis shows promise for helping determine lung function in lung cancer patients undergoing pulmonary lobectomy.
May 1, 2024
Lung Cancer
Interstitial lung abnormalities linked to respiratory disease risk
By Kate Madden Yee
CT imaging shows that severe acute respiratory disease events can be caused by quantitative interstitial abnormalities.
April 30, 2024
2024 04 30 Radiology Choi Figure2 Thumbnail
Understanding CT flow artifacts is key to better disease diagnosis
By Kate Madden Yee
Understanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.
April 26, 2024
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
CT-FFR reduces invasive procedures for coronary artery blockages
By Kate Madden Yee
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found.
April 11, 2024
Heart Pulmonary Trunk
Experts say consider BMI when imaging patients with chest pain
By Will Morton
A patient’s body mass index (BMI) has a significant effect on how much radiation exposure they receive from chest imaging in cases of suspected cardiac ischemia.
April 11, 2024
Heart Attack
Page 1 of 654
Next Page